Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
aTyr Pharma, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $169.36M | $169.36M - $169.36M | -$101.62M | $0.38 | 7 |
| Dec 2029 | $155.96M | $155.96M - $155.96M | -$93.57M | -$0.363 | 7 |
| Dec 2028 | $42.11M | $42.11M - $42.11M | -$25.26M | -$0.554 | 8 |
| Dec 2027 | $8.79M | $8.79M - $8.79M | -$5.27M | -$0.618 | 6 |
| Dec 2026 | $3.85M | $3.85M - $3.85M | -$2.31M | -$0.572 | 6 |
| Dec 2025 | $146.3K | $138.9K - $146.3K | -$87.8K | -$0.833 | 6 |
| Dec 2024 | $211.2K | $201.1K - $241.3K | -$126.7K | -$0.911 | 8 |
| Dec 2023 | $421.2K | $421.2K - $421.2K | -$252.7K | -$0.934 | 7 |
| Dec 2022 | $357.1K | $357.1K - $357.1K | -$214.3K | -$1.82 | 6 |
| Dec 2021 | $2.16M | $2.16M - $2.16M | -$1.29M | -$1.793 | 7 |
| Dec 2020 | $8.53M | $8.53M - $8.53M | -$5.12M | -$2.167 | 7 |
| Dec 2019 | $431.8K | $431.8K - $431.8K | -$259.1K | -$4.95 | 6 |